Regulations.gov document
Agency Information Collection Activities; Submission for Office of Management and Budget…
Notice · FDA-2020-N-1307 · posted Sep 13, 2021
Key facts
| Document ID | FDA-2020-N-1307-0016 |
|---|---|
| Title | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials |
| Document type | Notice |
| Subtype | 30 Day Proposed Information Collection |
| Agency | FDA |
| Docket | FDA-2020-N-1307 |
| Posted | Sep 13, 2021 |
| Federal Register citation | 86 FR 50888 |
| FR document number | 2021-19690 |
| Comment period opens | Sep 13, 2021 |
| Comments due | Oct 14, 2021 |
| Effective date | Sep 13, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: